GGrantIndex
← Leaderboards

Charles Sidoti

Brixton Biosciences, Inc.

$2,297,946
Attributed
$2,297,946
Total exposure
2
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1M · FY202225
$2M$1.5M$1M$500K$0
'22
'23
'24
'25

Funding mix

By agency

NIH$2,297,946 · 2

By mechanism

R44$2,045,816 · 1
R41$252,130 · 1

Top collaborators

No co-investigators on record.

Others in their field

Other Rising Stars on “Knee Pain

Research focus

Knee PainOpiate AddictionDevicesInjectionsKnee Replacement ArthroplastyNon-Opioid AnalgesicDesignArthralgiaEconomic BurdenInjectableAddictionBiomaterial CompatibilityNeedlesNerveAreaAdoptedCicatrixClinicDegenerative PolyarthritisCold TemperatureFreezingConsumptionCostOpioid

Grant awards (3)